The purpose of this paper was to compare gene expression in from matched specimens collected and RNA extracted using the PAXgene and Tempus systems and to investigate if identified differences were still present if extraction was not performed. The effect of collection system on differences in expression between patients with Type I diabetes and healthy controls was also explored.
Impact of blood collection and processing on peripheral blood gene expression profiling in type 1 diabetes.
Yip L, Fuhlbrigge R, Atkinson MA, Fathman CG
Purpose
Conclusion
RNA extracted from all specimens collected from healthy volunteers had a RIN ≥7.0 and a ratio of absorbance at 260 to 280 nm (A260/A280) of 2.00-2.15; further, no differences in RNA yield or quality were found between case-matched specimens collected and processed using the PAXgene and Tempus systems. Expression (determined by microarray) was very strongly correlated between case-matched Tempus and PAXgene specimens (r=0.97), but 901 genes (~5%) were differentially expressed (>2 fold) between the specimen types (614 genes were expressed at lower levels in PAXgene specimens compared to Tempus specimens. Differentially expressed genes showed enrichment for lymphocyte-signature genes and ribosomal protein genes, but not B-cell, T-cell or granulocyte genes. While most housekeeping genes were unaffected, RNA18S5 was found at 4-fold higher levels in PAXgene than Tempus specimens. The authors also found that 26 of the 90 genes previously identified to be differentially regulated in patients with type I diabetes were differentially expressed between tube types in case-matched specimens from healthy individuals. Real-time PCR and Nanostring confirmed that a subset of these genes had lower expression in PAXgene specimens compared to Tempus specimens. The variation between specimens was lower when analyzed by NanoString than microarray or real-time PCR. When the Tempus blood collection system was used, 4360 genes had levels that were >2-fold higher in patients diagnosed with type I diabetes than in healthy controls, although 316 of these genes were also affected by tube type. Differences in gene expression between Type I diabetes and control specimens were found to be tube type/RNA extraction system dependent. Many of the genes found to be differentially expressed when blood collection systems and RNA extraction kits from the same company were used (i.e., when RNA was extracted from PAXgene blood using the PAXgene system) displayed smaller or no difference in expression between lysates when commercial collection systems and extraction kits were mismatched, indicating that many of the differences observed between collection systems was introduced during extraction. Interestingly, ZNF680 levels were higher in PAXgene lysate and RNA extracts than in Tempus lysates and extracts, and this gene was enriched during RNA isolation in PAXgene but not Tempus specimens.
Studies (1)
Purpose
The study compared gene expression in case-matched blood specimens that were collected, processed, and underwent RNA extraction using the PAXgene or Tempus system, as well as when the RNA extraction step was omitted. The effect of blood collection system on differences in mRNA expression between patients with type I diabetes and healthy controls was also explored. Case-matched blood specimens were collected from nine healthy volunteers into PAXgene and Tempus tubes and RNA was extracted with the PAXgene Blood RNA Kit and the Tempus Spin RNA Isolation Kit, respectively. Blood was collected from patients with type I Diabetes at two sites, one which collected blood from 10 patients into Tempus tubes and extracted RNA using the KingFisher Purification System and another site which collected blood from 6 patients into PAXgene tubes and extracted RNA using the PAXgene Blood RNA Kit. RNA was quantified by NanoDrop spectrometry, and integrity was assessed using the RNA 6000 Nano Reagent Kit on a Bioanalyzer. Gene expression was analyzed using the SurePrint G3 Human Gene Expression 8×60K One-Color Microarray Kit and the levels of genes expressed in both tube types were compared using a t-test with Benjamini-Hochberg multiple testing correction and a cut off of >2-fold. Differential expression was confirmed by real-time PCR after normalization to Beta-actin. To investigate the effect of RNA extraction on the observed differences in expression, blood was collected from 11 healthy volunteers into PAXgene and Tempus tubes and RNA expression was analyzed in lysate using custom NanoString assays.
Summary of Findings
RNA extracted from all specimens collected from healthy volunteers had a RIN ≥7.0 and a ratio of absorbance at 260 to 280 nm (A260/A280) of 2.00-2.15. RNA yield and quality were comparable in case-matched specimens from healthy volunteers that were collected and processed using the PAXgene and Tempus Blood Collection Systems. A total of 17,843 genes were found in both specimen types (PAXgene and Tempus) from five or more of the nine healthy controls and expression was very strongly correlated between case-matched Tempus and PAXgene specimens (r=0.97). However, 901 genes (~5%) were differentially expressed (>2-fold difference) between the specimen types, of which 614 were expressed at lower levels in PAXgene specimens compared to Tempus specimens. Differentially expressed genes showed enrichment for lymphocyte-signature genes and ribosomal protein genes, but not B-cell, T-cell or granulocyte genes. While most of the housekeeping genes evaluated were unaffected, RNA18S5 was found at 4-fold higher levels in PAXgene than Tempus specimens. The authors also found that 26 of the 90 genes previously identified to be differentially regulated in patients with type I diabetes were differentially expressed between collection tube types in case-matched specimens from healthy individuals. Lower expression of COX6C, COX7B, LSM3, RPS24, RPL31, UQCRB, COMMD6 and SUB1 transcripts was observed in PAXgene specimens compared to Tempus specimens, which was confirmed by real-time PCR and NanoString analyses. Between-specimen variation was lower when analysis was by NanoString than microarray or real-time PCR. When Tempus blood specimens from patients with type I diabetes were compared with healthy controls collected using the same tube type, levels of 4,360 genes were higher by >2-fold in patients with type I diabetes and 316 of those genese were also affected by tube type. The authors confirmed lower levels of FASLG, FCRL6, GZMB, and KLRD1 mRNA in patients with type I diabetes compared to controls collected in Tempus tubes when analyzed by real-time PCR. However, when specimens were analyzed by NanoString, differences in mRNA levels between type I diabetes and control specimens were found to be tube type/RNA extraction system dependent. While mRNA levels of COX6C, COX7B, COMMD6, LSM3, RPS24, SUB1, KIF20B, and KIAA168 were lower and ZNF680 was higher in RNA extracted from PAXgene blood using the PAXgene system than in RNA extracted from Tempus blood using the Tempus system, no differences in COX6C, COX7B, COMMD6, LSM3, and SUB1 levels were found between lysates of PAXgene and Tempus blood. The differences in expression levels of RPS24, KIF20B, and KIAA1841 when PAXgene and Tempus specimens were compared were also smaller when lysates were analyzed as opposed to after RNA extraction, indicating much of the difference between the systems evaluated was introduced during extraction. Interestingly, ZNF680 levels were higher in PAXgene lysate and RNA extracts than Tempus lysates and extracts, and this gene was enriched during RNA isolation in PAXgene but not Tempus specimens.
Biospecimens
FluidBloodPreservation Types
PAXgeneOther PreservativeDiagnoses
Diabetes Type 1NormalPlatforms
RNAAutomated electrophoresis/BioanalyzerRNADNA microarrayRNAReal-time qRT-PCRRNASpectrophotometryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition HealthyType I diabetesBiospecimen Acquisition Type of collection container/solution PAXgene tubeTempus TubeBiospecimen Preservation Type of fixation/preservation PAXgeneTempusAnalyte Extraction and Purification Analyte isolation method No extraction performedPAXgene Blood RNA KitTempus Spin RNA Isolation Kit